Mannitol has several medical applications, primarily related to its osmotic properties. It is used to reduce intracranial pressure, treat cerebral edema, and manage intraocular pressure. It also serves as an osmotic diuretic, helping to increase urine production.
How is mannitol administered in medical settings?
Mannitol is typically administered intravenously as an injection or infusion [1]. This allows for rapid systemic absorption and delivery to target areas.
When is mannitol used to treat brain swelling?
Mannitol is employed in critical care settings to manage acute increases in intracranial pressure (ICP), which can occur after traumatic brain injury or stroke [2]. By drawing fluid from brain tissue into the bloodstream, it helps to reduce swelling and alleviate pressure on the brain [3].
What is the mechanism of action for mannitol as a diuretic?
As an osmotic diuretic, mannitol is filtered by the kidneys but not significantly reabsorbed. This increases the osmolarity of the tubular fluid, which in turn reduces water reabsorption and promotes increased urine output [4]. This effect can be beneficial in certain situations, such as preventing acute kidney injury [5].
Are there any risks or side effects associated with mannitol use?
Potential side effects of mannitol include dehydration, electrolyte imbalances, headache, dizziness, and nausea [1]. In some cases, it can also cause fluid overload or allergic reactions. Careful monitoring of fluid and electrolyte balance is necessary during administration [2].
Where can I find more information on drug patents and exclusivity for mannitol?
Information regarding the patent status and market exclusivity for various drugs, including mannitol, can be found on DrugPatentWatch.com [6]. This resource tracks patent expiry dates and potential generic competition.